Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like Rising antimicrobial resistance in STIs: A call for global action March 21, 2024 USC study unveils iron as key driver of lung inflammation in allergic asthma May 8, 2024 Restoring brain pathways to fight opioid addiction February 20, 2024